| Schwabe Pharma AG - Selomida Haut, Pulver zur Herstellung einer Lösung zum Einnehmen |
| 65359 | | 01 | | Selomida Haut | | Pulver zur Herstellung einer Lösung zum Einnehmen | | D11AZ | | Sonstige Dermatologika, Homöopathika | | 09.08.2016 | | |
|
| Composition |
| No.1 calcium fluoratum (HAB) D12 1.25 g, No.4 kalium chloratum (HAB) D6 (HAB 6) 1.25 g, No.6 kalium sulfuricum (HAB) D6 (HAB 6) 1.25 g, No.8 natrium chloratum (HAB) D6 (HAB 6) 1.25 g, No.11 silicea (HAB) D12 1.25 g, No.21 zincum chloratum D12 (HAB 6) 1.25 g, lactosum monohydricum 7.5 g, ad pulverem pro charta 7.5 g. |
| Packungsbestandteile |
| Pulver zur Herstellung einer Lösung zum Einnehmen | | | | | | Principe actif | Concentr. |
|---|
| No.4 Kalium Chloratum (Hab) D6 (Hab 6) | 1.25 g | | No.6 Kalium Sulfuricum (Hab) D6 (Hab 6) | 1.25 g | | No.8 Natrium Chloratum (Hab) D6 (Hab 6) | 1.25 g |
| | | | Agents auxilliaires | Concentr. |
|---|
| Lactose Monohydrate | 7.5 g | | N0.1 Calcium Fluoratum (Hab) D12 | 1.25 g | | N0.11 Silicea (Hab) D12 | 1.25 g | | No.21 Zincum Chloratum D12 (Hab 6) | 1.25 g |
|
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 30 x 7.5 g | | | D | | Non | | 002 | 7.5 g | | | D | | Oui |
|
